TP53 and hepatocellular carcinoma: HBV-HCC pathogenesis: HBV-HCC pathways typically include aberrant miRNA expression in the RB1-TP53 suppressor networks, the WNT pathway, PI3K/MAPK pathways and the JAK/STAT pathway [128,129].